Harvard Bioscience Inc (NASDAQ:HBIO)

4.10
Delayed Data
As of 3:59pm ET
 0.00 / 0.00%
Today’s Change
1.98
Today|||52-Week Range
6.29
+48.01%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-19.0M-4.3M-865.0K-2.9M
 
 
 
 
 
Depreciation4.6M4.3M3.8M7.8M
 
 
 
 
 
Total Other Cash Flow2.8M5.7M3.5M2.5M
 
 
 
 
 
Funds From Operations3.4M5.4M4.9M4.6M
 
 
 
 
 
Funds From/For Other Operating Expenses2.7M41.0K3.8M1.7M
 
 
 
 
 
Net Cash Flow - Operating Activities705.0K5.4M1.1M2.9M
 
 
 
 
 
 
InvestingCapital Expenditures-3.0M-1.4M-890.0K-986.0K
 
 
 
 
 
Fixed Asset Disposal6.0K1.4M12.0K15.8M
 
 
 
 
 
Net Assets From Acquisitions -4.5M0.000.00-68.5M
 
 
 
Other Investing - Uses-18.0K0.000.000.00
 
 
Net Cash Flow Investing-7.5M-62.0K-917.0K-53.8M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings5.8M4.0M2.8M68.7M
 
 
 
 
 
Long Term Debt Reduction-8.4M-9.1M-4.7M-20.2M
 
 
 
 
 
Net Proceeds Stock Sale2.0M182.0K160.0K4.6M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-540.0K-4.9M-1.8M53.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-38.0K-1.6M1.8M299.0K
 
 
 
 
 
 
Net Change In Cash-7.4M453.0K-1.7M2.1M